Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States

• Main Authors: Wentao Tian (Author), Jiaoyang Ning (Author), Liu Chen (Author), Yu Zeng (Author), Yin Shi (Author), Gang Xiao (Author), Shuangshuang He (Author), Guilong Tanzhu (Author), Rongrong Zhou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Tumor treating fields (TTF) was first approved for treatment of glioblastoma. Recently, the LUNAR study demonstrated that TTF + standard therapy (ST) extended survival in patients with advanced non-small cell lung cancer (NSCLC). This primary objective of this study is to analyze the cos...